Predictive value of decreased p27(Kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients

British Journal of Cancer

Volumn 81, Issue 6, 1999, Pages 1052-1058

  Kuczyk, M ^a   Machtens, S ^a   Hradil, K ^a   Schubach, J ^a   Christian, W ^a   Knuchel R ^c   Hartmann, J ^b   Bokemeyer, C ^b   Jonas, U ^a   Serth, J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

p27(Kip1) gene; Prognosis; Prostate cancer

Indexed keywords

PROTEIN P27;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION;

ADENOCARCINOMA; AGED; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0032700604     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690806     Document Type: Article

References (30)

1. Ackerman DA, Barry JM, Wicklund RA, Olson N and Lowe BA (1993) Analysis of high risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. J Urol 150: 1845-1850
2. Adolfsson J, Carstensen T and Lowhagen T (1992) Deferred treatment in localised prostate cancer. Br J Urol 69: 183-187
3. Kipl, to regions involved in human cancer. Cancer Res 55: 1199-1205
4. Kipl levels with recurrence and survival in patients with stage C prostate carcinoma. J Natl Cancer Inst 90: 916-920
5. Kipl induces cell cycle arrest and loss of cyclin cdk activity in human breast cancer cells. Oncogene 14: 2283-2289
6. Elledge SJ (1996) Cell cycle checkpoints: preventing an identity crisis. Science 274: 1664-1672
7. Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M and Giordano A (1997) Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 57: 3381-3385
8. Ferrando AA, Balbin M, Pendas AM, Vizoso F, Velasco G and Lopez-Otin C (1996) Mutational analysis of the human cyclin-dependent kinase inhibitor p27Kipl in primary breast carcinomas. Hum Genet 97: 91-94
9. Fredersdorf S, Burns J, Milne AM, Packham G, Falls L, Gillett CE, Royds JA, Peston D, Hall PA, Hanby AM, Barnes DM, Shousha S, O Hare MJ and Lu X (1997) High level expression of p27(kipl) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kipl) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 94: 6380-6385
10. George NJR (1988) Natural history of localised prostate cancer managed by conservative therapy alone. Lancet 1: 494-497
11. Hermanek P and Sobin LH (eds.) (1992) UICC TNM Classification of Malignant Tumours, 4th edn, 2nd revision. Springer, Berlin.
12. Johansson JE, Adami HO, Andersson SO, Bergström R, Holmberg L and Krusemo UB (1992) High 10-year survival rate in patients with early untreated prostate cancer. JAMA 267: 2191-2196
13. Kipl) of cyclin-dependent kinase 4 activation. Cell 79: 487-496
14. Kawamata N, Seriu T, Koeffler HP and Bartram CR (1996) Molecular analysis of the cyclin-dependent kinase inhibitor family: p16 (CDKN2/MTS1/INK4A), p18 (INK4C) and p27 (Kipl) gents in neuroblastomas. Cancer 77: 570-575
15. Kawasaki T, Tomita Y, Bilim V, Takeda M, Takahashi K and Kumanishi T (1996) Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/C1PI and/or p53 gene alterations. Int J Cancer 68: 501-505
16. Kuczyk MA, Serth J, Bokemeyer C, Machtens S, Minssen A, Bathke W, Hartmann J and Jonas U (1998) The prognostic value of p53 for the long-term and recurrence-free survival following radical prostatectomy. Eur J Cancer 34: 679-686
17. Lee CCR, Yamamoto S, Wanibuchi H, Wada S, Sugimura K, Kishimoto T and Fukushima S (1997) Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation. Cancer Res 57: 4765-4776
18. Martin E, Cacheux V, Cave H, Lapierre JM, Le Paslier D and Grandchamp B (1995) Localization of the CDKN4/p27(Kipl) gene to human chromosome 12p12.3. Hum Genet 96: 668-670
19. McGarvey TW and Malkowicz SB (1996) The role of the celt cycle in genitourinary carcinoma. World J Urol 14: 310-317
20. Nasmyth K (1996) Viewpoint: putting the cell cycle in order. Science 274: 1643-1645
21. Porker SL, Tong T, Bolden S and Wingo PA (1996) Cancer Statisties 1906. CA Cancer J Clin 46: 5-27
22. Kip1 a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to call cycle arrest. Genes Dev 8: 9-22
23. Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P and Massague J (1994b) Cloning of p27(Kipl), a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66
24. Ponce-Castaneda MV, Lee MH, Latres E, Polyak K, Lacombe L and Montgomery K (1995) P27 Kipl: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 55: 1211-1214
25. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR and Roberts JM (1997) Expression of cell-cycle regulators p27Kipl and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3: 222-225
26. Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW and Koeffler HP (1996) p27/Kipl mutation found in breast cancer. Cancer Res 56: 2400-2404
27. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whitemore AS and Schmid HP (1993) Localized prostate cancer relationship of tumor volume to clinical significance for the treatment of prostate cancer. Cancer 71: 933-938
28. Wu G, Fan RS, Li W, Ko TC and Brattain MG (1097) Modulation of cell cycle control by vitamin D3 and its analogue, EB 1089, in human breast cancer cells. Oncogene 15: 1555-1563
29. Yang RM, Naitoh J, Murphy M, Wang HJ, Phillipson J, De Kemion JB, Loda M and Reiter RE (1998) Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J Urol 159: 941-945
30. Yasui W, Kudo Y, Semba S, Yokozaki H and Tahara E (1997) Reduced expression of cyclin dependent kinase inhibitor p27Kipl is associated with advanced stage and invasiveness of gastric carcinomas. Jpn J Cancer Res 88: 625-629